Loading patent…
AssigneeTempest Therapeutics, Inc.
InventorsYalda Bravo, Austin Chih-Yu Chen, Jinyue Ding, Robert Gomez, Heather Lam, Joe Fred Nagamizo, Renata Marcella Oballa, David Andrew Powell, Tao Sheng
Estimating the term…
Compounds, compositions and methods are provided for modulating the activity of EP2 and EP4 receptors, and for the treatment, prevention and amelioration of one or more symptoms of diseases or disorders related to the activity of EP2 and EP4 receptors. In certain embodiments, the compounds are antagonists of both the EP2 and EP4 receptors.
A method for the treatment of an EP4-mediated cancer in a patient comprising administering to the patient a compound that is selected from the group consisting of:
Dependencies are inferred from the claim text.